Candida species, including C. albicans, are part of the mucosal flora of most healthy women,
and inhabit the gastrointestinal and genitourinary tracts. Under favourable conditions, they …

Candida glabrata has thoroughly adapted to successfully colonize human mucosal
membranes and survive in vivo pressures. prior to and during antifungal treatment. Out of all …

The composition of the microbiota is the focus of many recent publications describing the
effects of the microbiota on host health. In recent years, research has progressed further …

Candida auris is a recently emerged multidrug-resistant fungal pathogen causing severe
illness in hospitalized patients. C. auris is most closely related to a few environmental or …

With the increasing morbidity and mortality of invasive fungal infections and the emergence
of severe antifungal drug resistance, new drug targets and novel antifungal agents are …

Breast cancer is susceptible to Candida infections, and candidiasis has an enhancing effect
on the progression and metastasis of tumor. Breast cancer and concurrent candidiasis …

Over the past several decades, invasive fungal infections, especially candidiasis, have
caused dramatic morbidity and mortality due to ineffective antifungal drugs and severe drug …

Clinical treatment of candidiasis has suffered from increasingly severe drug resistance and
limited efficacy. Thus, novel strategies to deal with drug resistance are highly desired to …

Due to the evolution and development of antifungal drug resistance, limited efficacy of
existing drugs has led to high mortality in patients with serious fungal infections. To develop …

Invasive fungal infections (particularly candidiasis) are emerging as severe infectious
diseases worldwide. Because of serious antifungal drug resistance, therapeutic efficacy of …